BOCK

General

Laser Hair Removal Usually Thins Hair. A Minority Grow More, and the Risk Is Not Evenly Shared.

In the Grimm tale of Rapunzel, a girl is shut in a tower, and her hair grows so long that a visitor can climb it like a ladder. Hair is the one part of the body that seems to keep its own counsel.

Some patients arrive in my clinic in Seoul with that fear turned around. They paid for laser hair removal, and a few months later there is more hair, or darker hair, in the very place that was treated. The medical name is paradoxical hypertrichosis.

It is uncommon, and it should not scare anyone away from a well-established treatment. But the published numbers are less reassuring than the brochures. The rate depends heavily on who is treated and who is counting, and the risk is not evenly shared. That is a reason to talk about it before the first session, not after the fourth.


What is paradoxical hypertrichosis after laser hair removal?

Paradoxical hypertrichosis is new, thicker or darker hair growing in or next to an area that was treated with a hair removal laser. It is the opposite of the intended result, which is why it is called paradoxical.

Why it happens is not settled. A 2025 letter in the Journal of Cosmetic Dermatology states that the mechanisms remain speculative and that the ideal fluence, the energy delivered per unit area, is not yet known (Moriguchi, 2025). That uncertainty matters. If nobody can say why it happens, nobody can promise to prevent it.


How common is paradoxical hypertrichosis after laser hair removal?

Published rates range from 0.34% to 16.2%, a gap of almost fifty-fold. The gap tells you more than either number alone.

Inoue et al. (2024) reviewed patients who had laser hair removal between November 2018 and November 2020. Of 7,381 patients, 25 (0.34%) showed increased hair growth. Nearly all had been treated with an alexandrite laser (24 of 25, P < .01), though about 70% of treatments in the series used alexandrite.

Qeyam et al. (2025) followed female patients aged 16 and older who had long-pulse alexandrite laser treatment of facial hair in Jordan, from March 2023 to December 2024. They reported a facial paradoxical hypertrichosis prevalence of 16.2%, which they describe as higher than previously reported.

The studies differ in site, sex, design and how cases were found, so they cannot be lined up as a simple comparison. A review of records finds the patients who complained. A prospective study that asks questions finds more.


Who is at higher risk of paradoxical hypertrichosis?

Men, people with hormonal conditions such as polycystic ovary syndrome, and people who have many sessions or little sun protection show higher rates in the available studies. None of these studies is a randomized trial, so these are associations.

Moriguchi (2025) reviewed charts at a single clinic in Japan from March 2022 to January 2024: 318 patients (63 men, 255 women) with East Asian skin, treated with 755 nm alexandrite and 1064 nm Nd:YAG platforms. Paradoxical hypertrichosis occurred in 33.3% of men versus 9.0% of women (p < 0.05). In men it clustered on the back (10 of 63, 15.9%), upper arms (11.1%) and shoulders (7.9%). In women it appeared on the face (9 of 255, 3.5%), neck (3.1%) and upper arms (2.0%). Extensive, multi-area spread was seen in 17.4% of men and 1.6% of women.

In the Jordanian cohort, the condition was more frequent among women with polycystic ovary syndrome (33.3% vs. 14.1%, P < 0.001), irregular menstrual cycles (33.3% vs. 12.6%, P = 0.001) and a family history of hirsutism (27.8% vs. 13.8%, P = 0.001). It was also more frequent after 6 to 10 laser sessions (30.9% vs. 6.8%, P = 0.001). Regular sunblock use went with less of it (12.1% vs. 36.1%, P = 0.001). Oral contraceptive use showed no clear association (P = 0.19) (Qeyam et al., 2025).

Sun protection also appeared in the large review, where daily sun protection was associated with lower incidence (odds ratio 0.41, P < .05). That series identified the periareolar area as high-risk (Inoue et al., 2024).

Not everything agrees. Inoue et al. (2024) found no difference by skin type, while Qeyam et al. (2025) reported higher rates in Fitzpatrick types III and IV. Those are different populations and different designs.


Does the choice of laser change the odds?

Possibly, but the evidence cannot separate the device from the patient. In the large review, diode laser treatment was associated with a lower incidence than alexandrite (Inoue et al., 2024). Moriguchi (2025) studied a combined alexandrite and Nd:YAG platform and did not compare devices.

On effectiveness, the picture is more even. A systematic review and meta-analysis of 12 comparative trials (nine randomized, three quasi-randomized) in Fitzpatrick skin types III to VI concluded that outcomes for different in-office lasers and intense pulsed light are broadly similar, although alexandrite outperformed intense pulsed light on hair count reduction (standardized mean difference −1.7, 95% CI −2.6 to −0.78) (Dorgham & Dorgham, 2020).

This is why a device choice made on hair removal efficacy alone leaves a question open. The trials in that meta-analysis were designed to measure hair reduction, not to count rare paradoxical growth.


What are the limits of this evidence?

Some will say a risk of 0.34% is rare enough to leave out of the consultation. That is partly true for the lowest estimate. But the same literature contains a prospective estimate of 16.2% and a male rate of 33.3% in one clinic.

The studies share real limits. All of the paradoxical hypertrichosis data are observational. Moriguchi (2025) is a single-centre chart review and a letter. Qeyam et al. (2025) is from one hospital and reports many risk factors from group comparisons. Inoue et al. (2024) cannot tell us about patients treated with other devices in other settings. Even the meta-analysis was not built to detect this outcome (Dorgham & Dorgham, 2020).

None of this proves that the risk is high. It shows that the risk has not been measured well, and that it is not the same for every patient.


Conclusion

Laser hair removal is an effective treatment for most people, and paradoxical hypertrichosis is a recognised, uncommon, but not trivial outcome. The estimates run from 0.34% to 16.2%, and the patient groups most affected in these studies were men, people with polycystic ovary syndrome or irregular cycles, and people with a family history of hirsutism.

A good consultation reflects that. It asks about hormonal history and family history before the first session, names this outcome in the consent discussion, and talks about daily sun protection, which was linked to fewer cases in two separate studies. It also looks at the first response with the patient rather than assuming that more sessions will fix it.

In the fairy tale, the hair grew without anyone asking. In the clinic, nothing about it should come as a surprise.

For clinical assessments and consultation in Seoul: itsdrbock.com


References

Dorgham, N. A., & Dorgham, D. A. (2020). Lasers for reduction of unwanted hair in skin of colour: A systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology, 34(5), 948–955. https://doi.org/10.1111/jdv.15995

Inoue, Y., Nishioka, H., Inukai, M., Shimizu, Y., Kimura, M., Akita, H., & Okumoto, T. (2024). What are the factors that induce paradoxical hypertrichosis after laser hair removal? Aesthetic Surgery Journal, 44(5), NP347–NP353. https://doi.org/10.1093/asj/sjae018

Moriguchi, S. (2025). Gender disparities in paradoxical hypertrichosis after laser hair removal. Journal of Cosmetic Dermatology, 24(5), Article e70194. https://doi.org/10.1111/jocd.70194

Qeyam, H., Elrafi, A., Alomari, S., & Jaradat, M. (2025). Predictors and prevalence of paradoxical hypertrichosis in alexandrite laser-based facial hair removal: Results from a prospective clinical study. Lasers in Medical Science, 40(1), Article 240. https://doi.org/10.1007/s10103-025-04498-5

More From the Blog